Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
TRUQAP recommended by FDA advisory panel for PTEN-deficient prostate cancer
Friday, May 01, 2026US Food and Drug Administrations Oncologic Drugs Advisory Committee has supported the use of TRUQAP capivasertib in combination with abiraterone and androgen deprivation therapy ADT for patients
Evotec secures grants to advance tuberculosis treatment
Thursday, April 30, 2026Evotec SE has secured two new grants from the Bill Melinda Gates Foundation to support drug discovery and translational research in tuberculosis TB This follows four earlier TB grants from the foundation valued at million over months and million...
Huahui Health signs global agreement with BeOne Medicines for oncology drug HH160
Thursday, April 30, 2026Huahui Health has entered into a global exclusive option licence and collaboration agreement with BeOne Medicines for HH a novel trispecific antibody designed for cancer immunotherapy The agreement grants BeOne Medicines an exclusive option to develo...
Remepy Partners with Merck to Develop Hybrid Drugs Across Therapeutic Areas
Wednesday, April 29, 2026Remepy has entered into a collaboration with Merck to advance the development of hybrid drugs across multiple therapeutic areashe initial phase of the partnership will focus on selected programmes in the United States particularly in a rare tumour se...
Gilead Acquires Arcellx to Strengthen Cancer Treatment Pipeline
Wednesday, April 29, 2026Gilead Sciences has completed its acquisition of Arcellx in a deal valued at approximately billion Anitocel is a BCMAdirected CAR Tcell therapy that uses a Ddomain binder This design aims to improve CAR expression while reducing unwanted immune acti...
Taiho Oncology Announces FDA Acceptance of Zipalertinib Application for Advanced Lung Cancer
Wednesday, April 29, 2026Taiho Oncology along with Taiho Pharmaceutical and Cullinan Therapeutics has announced that the US Food and Drug Administration FDA has accepted a New Drug Application NDA for zipalertinib
Lilly to Acquire Ajax Therapeutics to Advance Treatments for Myelofibrosis and Polycythaemia Vera
Tuesday, April 28, 2026Eli Lilly and Company has entered into a definitive agreement to acquire Ajax Therapeutics Ajaxs lead candidate AJ is an investigational oncedaily oral Type II JAK inhibitor It is currently being evaluated in a Phase clinical trial
Terns Pharmaceuticals Receives Breakthrough Therapy for TERN-701 in Chronic Myeloid Leukemia (CML)
Tuesday, April 28, 2026Terns Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD to TERN an investigational oral allosteric BCRABL inhibitor
Cipla Secures US FDA Approval for First AB-Rated Generic of Ventolin HFA
Friday, April 24, 2026Cipla and its subsidiary Cipla USA have received final approval from the US Food and Drug Administration FDA for their Abbreviated New Drug Application ANDA for Albuterol Sulfate Inhalation Aerosol mcg per actuation The product is the first ABrated...
AbbVie to Invest $1.4 Billion in New Manufacturing Campus in North Carolina
Thursday, April 23, 2026AbbVie has announced plans to invest billion in the development of a pharmaceutical manufacturing campus in Durham North Carolina The acre site will incorporate advanced manufacturing systems
